DEVELOPMENT SAFETY UPDATE REPORT CoVigi 25.2.2023 – 1.11.2023

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	DEMLOVÁ Regina JANSKÁ Kateřina
Year of publication	2023
MU Faculty or unit	Faculty of Medicine
Web	CoVigi
Description	Objective of the clinical trial CoVigi was to obtain information on the efficacy and safety of COVID-19 vaccines by determining antibody levels and cellular immunity, collecting data on adverse events and effects, and monitoring incidence of COVID-19 disease over the period of 2 years. In addition, the circulating immune profile of oncological patients was monitored and the determined objectives and parameters were evaluated in connection with the type of oncological treatment administered. 559 adult subjects were enrolled in 3 study centers. The trial´s sponsor is the Masaryk University.
Related projects:	CZECRIN - Czech National Node to the European Clinical Research Infrastructure Network